CORRECTION article

Front. Cardiovasc. Med., 05 March 2025

Sec. Coronary Artery Disease

Volume 12 - 2025 | https://doi.org/10.3389/fcvm.2025.1580343

Corrigendum: Sodium–glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure

  • 1. Pharmacy Department, Hamad Medical Corporation, Doha, Qatar

  • 2. Cardiology Department, Hamad Medical Corporation, Doha, Qatar

  • 3. Anesthesiology, Intensive Care and Perioperative Medicine Department, Hamad Medical Corporation, Doha, Qatar

  • 4. Internal Medicine Department, Rochester Regional Health, New York, NY, United States

  • 5. Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar

  • 6. Endocrinology Department, Hamad Medical Corporation, Doha, Qatar

  • 7. Department of Clinical Pharmacy and Practice, Qatar University, Doha, Qatar

  • 8. Interventional Cardiology Department, Hamad Medical Corporation, Doha, Qatar

  • 9. Heart Failure Department, Hamad Medical Corporation, Doha, Qatar

  • 10. Department of Medicine, Weill Cornell Medicine, Doha, Qatar

Article metrics

View details

1k

Views

301

Downloads

In the published article, there was an error in the Funding statement. The authors declared receiving no financial support for the research, authorship, or publication of this article. The correct Funding statement appears below.

Statements

Funding

The author(s) declare financial support was received for the research and/or publication of this article. The Medical Research Center at Hamad Medical Corporation provided the publication open-access fees.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

acute coronary syndrome, heart failure, sodium–glucose cotransporter-2 (SGLT-2) inhibitors, HF hospitalization, cardioprotection

Citation

Rahhal A, Hamamyh T, Chapra A, Zaza KJ, Najim M, Hemadneh M, Faraj H, Kanjo W, Yasin A, Toba H, Mohammed W, Hamad MK, Al-Tikrety N, Baraa Habib M, Awaisu A, Mahfouz A, Alyafei S, Arabi AR, Patel A and Al-Hijji M (2025) Corrigendum: Sodium–glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure. Front. Cardiovasc. Med. 12:1580343. doi: 10.3389/fcvm.2025.1580343

Received

20 February 2025

Accepted

24 February 2025

Published

05 March 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

12 - 2025

Updates

Copyright

* Correspondence: Alaa Rahhal

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics